Trial Profile
International multicentre randomized controlled trial of G17DT in patients with advanced pancreatic cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2012
Price :
$35
*
At a glance
- Drugs Polyclonal antibody stimulator (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Apr 2012 Final results published in the Pancreas.
- 05 Nov 2010 New trial record.
- 01 May 2001 Recruitment initiated.